Mouse and human micronucleus models for assessing genotoxicity of whole foods in intervention studies

M Fenech1

  • 1C.S.I.R.O. Division of Human Nutrition, Adelaide, Australia.

Mutation Research
|November 1, 1993
PubMed

Insights

Genotoxicity assays like the micronucleus test can evaluate the cancer-causing potential of foods in vivo. These practical methods are applicable to both human and rodent studies for dietary interventions.

Area of Science:

  • Food science
  • Toxicology
  • Genetics

Background:

  • Assessing the in vivo carcinogenic or anti-carcinogenic potential of foods requires reliable genotoxicity assays.
  • Traditional and novel food components necessitate evaluation for their impact on health.
  • Classical genotoxicity assays offer a framework for such assessments.

Purpose of the Study:

  • To highlight the utility of micronucleus techniques for evaluating food-induced genotoxicity in vivo.
  • To demonstrate the application of these assays in the context of dietary interventions.
  • To compare recent literature and ongoing research for practical insights.

Main Methods:

  • Micronucleus assays in peripheral blood erythrocytes.
  • Micronucleus assays in lymphocytes.
  • In vivo assessment following dietary interventions with whole foods.

Main Results:

  • Micronucleus techniques effectively assess chromosome-damaging effects.
  • These methods are practical and adaptable for both human and rodent models.
  • The study illustrates the application through literature and ongoing research examples.

Conclusions:

  • Micronucleus assays are valuable tools for assessing the genotoxic and potential carcinogenic/anti-carcinogenic effects of foods.
  • The practicality and cross-species applicability make them suitable for dietary intervention studies.
  • Further research and application of these methods are encouraged for food safety and health evaluations.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...